Loading clinical trials...
Loading clinical trials...
A Single Centre, Placebo-Controlled, Double-Masked, Sequential Designed Study to Evaluate 3 Ophthalmic Formulations of AMA0076 in Healthy Subjects
Conditions
Interventions
AMA0076
Placebo
Locations
1
United Kingdom
Ruddington, Nottingham, United Kingdom
Start Date
September 1, 2013
Primary Completion Date
December 1, 2013
Completion Date
December 1, 2013
Last Updated
May 2, 2014
NCT04354545
NCT07463950
NCT07298356
NCT07363824
NCT07396441
NCT06979752
Lead Sponsor
Amakem, NV
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions